Title of article
Design and Application of In Vivo FRET Biosensors to Identify Protein Prenylation and Nanoclustering Inhibitors Original Research Article
Author/Authors
Monika K?hnke، نويسنده , , Steven Schmitt، نويسنده , , Nicholas Ariotti، نويسنده , , Andrew M. Piggott، نويسنده , , Robert G. Parton، نويسنده , , Ernest Lacey، نويسنده , , Robert J. Capon، نويسنده , , Kirill Alexandrov، نويسنده , , Daniel Abankwa، نويسنده ,
Issue Information
ماهنامه با شماره پیاپی سال 2012
Pages
9
From page
866
To page
874
Abstract
Protein prenylation is required for membrane anchorage of small GTPases. Correct membrane targeting is essential for their biological activity. Signal output of the prenylated proto-oncogene Ras in addition critically depends on its organization into nanoscale proteolipid assemblies of the plasma membrane, so called nanoclusters. While protein prenylation is an established drug target, only a handful of nanoclustering inhibitors are known, partially due to the lack of appropriate assays to screen for such compounds. Here, we describe three cell-based high-throughput screening amenable Förster resonance energy transfer NANOclustering and Prenylation Sensors (NANOPS) that are specific for Ras, Rho, and Rab proteins. Rab-NANOPS provides the first evidence for nanoclustering of Rab proteins. Using NANOPS in a cell-based chemical screen, we now identify macrotetrolides, known ionophoric antibiotics, as submicromolar disruptors of Ras nanoclustering and MAPK signaling.
Journal title
Chemistry and Biology
Serial Year
2012
Journal title
Chemistry and Biology
Record number
1160273
Link To Document